Related Experiment Videos
[Generalized periarticular calcinosis. Generalized hydroxylapatite disease].
Schweizerische Medizinische Wochenschrift
|April 7, 1979
Summary
Generalized periarticular calcinosis presents as brief, joint-specific inflammation, often linked to hydroxyapatite crystal deposition. Current treatments offer unsatisfactory symptom relief for this metabolic disorder.
Area of Science:
- Rheumatology
- Biochemistry
- Pathology
Context:
- Generalized periarticular calcinosis is a clinical syndrome characterized by episodic, monoarticular arthritic or tenosynovitis flares.
- A chronic primary course is uncommon, with diagnosis hinging on identifying periarticular calcifications, specifically hydroxyapatite crystals.
Purpose:
- To elucidate the pathogenic classification and etiological basis of generalized periarticular calcinosis.
- To review diagnostic criteria and therapeutic challenges associated with this condition.
Summary:
- Periarticular calcifications, identified as hydroxyapatite, are believed to trigger inflammatory episodes, classifying the condition as crystalline synovitis.
- Etiology likely involves a combination of genetic and acquired metabolic abnormalities.
- Current understanding of pathogenesis limits targeted modification of calcification.
Impact:
- The symptomatic nature of current therapies, including non-steroid anti-inflammatories, corticosteroids, and colchicine, proves largely unsatisfactory.
- Further research into pathogenesis is needed for effective treatment development.